Immunoblotting analysis demonstrated that HSPA12B expression was increased significantly by 5.7‐fold 24 hrs post‐stroke compared to sham controls (P < 0.01; Fig. 1A). The gene discussed is HSPA12B; the disease is stroke disorder.